sanofi-aventis U.S. LLC drugs

14 results
  • admelog

    (insulin lispro)
    Sanofi-Aventis U.S. LLC
    ADMELOG is indicated for improving glycemic control in both adult and pediatric patients with diabetes mellitus.
  • apidra

    (insulin glulisine)
    sanofi-aventis U.S. LLC
    APIDRA is indicated for improving glycemic control in both adult and pediatric patients with diabetes mellitus.
  • avapro

    (irbesartan)
    Sanofi-Aventis U.S. LLC
    AVAPRO® is indicated for treating hypertension, reducing blood pressure to lower cardiovascular event risks, and for managing diabetic nephropathy in type 2 diabetes patients with hypertension and proteinuria. It may be used alone or with other antihypertensive agents to achieve blood pressure goals and protect kidney function.
  • dupixent

    (Dupilumab)
    sanofi-aventis U.S. LLC
    DUPIXENT is indicated for treating moderate-to-severe atopic dermatitis in patients 6 months and older, asthma in patients 6 years and older, chronic rhinosinusitis with nasal polyps in patients 12 and older, eosinophilic esophagitis, prurigo nodularis, inadequate COPD management, chronic spontaneous urticaria over 12, and bullous pemphigoid in adults.
  • elitek

    (rasburicase)
    Sanofi-Aventis U.S. LLC
    Elitek is indicated for the initial management of elevated plasma uric acid levels in pediatric and adult patients with leukemia, lymphoma, and solid tumors undergoing anticancer therapy that may cause tumor lysis. It is intended for a single course of treatment.
  • fexinidazole

    (Fexinidazole)
    Sanofi-Aventis U.S. LLC
    Fexinidazole Tablets are indicated for treating both first-stage and second-stage human African trypanosomiasis (HAT) caused by *Trypanosoma brucei gambiense* in patients aged 6 years and older, weighing at least 20 kg. Limited use is advised in severe second-stage HAT cases with high CSF-WBC counts.
  • jevtana

    (cabazitaxel)
    Sanofi-Aventis U.S. LLC
    JEVTANA® is indicated for use in combination with prednisone to treat patients with metastatic castration-resistant prostate cancer who have previously undergone treatment with a docetaxel-containing regimen.
  • kevzara

    (sarilumab)
    sanofi-aventis U.S. LLC
    KEVZARA is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis and polymyalgia rheumatica who have had inadequate responses to DMARDs or corticosteroids. It is also indicated for active polyarticular juvenile idiopathic arthritis in patients weighing 63 kg or more.
  • lantus

    (insulin glargine)
    sanofi-aventis U.S. LLC
    LANTUS is indicated for improving glycemic control in adults and pediatric patients with diabetes mellitus. It is not recommended for treating diabetic ketoacidosis.
  • merilog

    (insulin aspart-szjj)
    Sanofi-Aventis U.S. LLC
    Merilog is indicated for improving glycemic control in both adults and pediatric patients with diabetes mellitus.